These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 35218219)

  • 1. Deep generative models for ligand-based de novo design applied to multi-parametric optimization.
    Perron Q; Mirguet O; Tajmouati H; Skiredj A; Rojas A; Gohier A; Ducrot P; Bourguignon MP; Sansilvestri-Morel P; Do Huu N; Gellibert F; Gaston-Mathé Y
    J Comput Chem; 2022 Apr; 43(10):692-703. PubMed ID: 35218219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deep Learning Applied to Ligand-Based De Novo Drug Design.
    Palazzesi F; Pozzan A
    Methods Mol Biol; 2022; 2390():273-299. PubMed ID: 34731474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive assessment of deep generative architectures for de novo drug design.
    Wang M; Sun H; Wang J; Pang J; Chai X; Xu L; Li H; Cao D; Hou T
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34929743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial Intelligence, Machine Learning, and Deep Learning in Real-Life Drug Design Cases.
    Muller C; Rabal O; Diaz Gonzalez C
    Methods Mol Biol; 2022; 2390():383-407. PubMed ID: 34731478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unleashing the power of generative AI in drug discovery.
    Gangwal A; Lavecchia A
    Drug Discov Today; 2024 Jun; 29(6):103992. PubMed ID: 38663579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular design in drug discovery: a comprehensive review of deep generative models.
    Cheng Y; Gong Y; Liu Y; Song B; Zou Q
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34415297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AutoDesigner, a
    Bos PH; Houang EM; Ranalli F; Leffler AE; Boyles NA; Eyrich VA; Luria Y; Katz D; Tang H; Abel R; Bhat S
    J Chem Inf Model; 2022 Apr; 62(8):1905-1915. PubMed ID: 35417149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De novo generation of dual-target ligands using adversarial training and reinforcement learning.
    Lu F; Li M; Min X; Li C; Zeng X
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34410338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Has Artificial Intelligence Impacted Drug Discovery?
    Patronov A; Papadopoulos K; Engkvist O
    Methods Mol Biol; 2022; 2390():153-176. PubMed ID: 34731468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The power of deep learning to ligand-based novel drug discovery.
    Baskin II
    Expert Opin Drug Discov; 2020 Jul; 15(7):755-764. PubMed ID: 32228116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deep Reinforcement Learning for Multiparameter Optimization in
    Ståhl N; Falkman G; Karlsson A; Mathiason G; Boström J
    J Chem Inf Model; 2019 Jul; 59(7):3166-3176. PubMed ID: 31273995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intelligently Applying Artificial Intelligence in Chemoinformatics.
    Sharma S; Sharma D
    Curr Top Med Chem; 2018; 18(20):1804-1826. PubMed ID: 30465503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New avenues in artificial-intelligence-assisted drug discovery.
    Cerchia C; Lavecchia A
    Drug Discov Today; 2023 Apr; 28(4):103516. PubMed ID: 36736583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generative machine learning for de novo drug discovery: A systematic review.
    Martinelli DD
    Comput Biol Med; 2022 Jun; 145():105403. PubMed ID: 35339849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNMG: Deep molecular generative model by fusion of 3D information for de novo drug design.
    Song T; Ren Y; Wang S; Han P; Wang L; Li X; Rodriguez-Patón A
    Methods; 2023 Mar; 211():10-22. PubMed ID: 36764588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artificial Intelligence in
    Kumar R; Sharma A; Alexiou A; Ashraf GM
    Curr Top Med Chem; 2022; 22(30):2483-2492. PubMed ID: 36263480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The AI-driven Drug Design (AIDD) platform: an interactive multi-parameter optimization system integrating molecular evolution with physiologically based pharmacokinetic simulations.
    Jones J; Clark RD; Lawless MS; Miller DW; Waldman M
    J Comput Aided Mol Des; 2024 Mar; 38(1):14. PubMed ID: 38499823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic Algorithm-Based Receptor Ligand: A Genetic Algorithm-Guided Generative Model to Boost the Novelty and Drug-Likeness of Molecules in a Sampling Chemical Space.
    Wang M; Wu Z; Wang J; Weng G; Kang Y; Pan P; Li D; Deng Y; Yao X; Bing Z; Hsieh CY; Hou T
    J Chem Inf Model; 2024 Feb; 64(4):1213-1228. PubMed ID: 38302422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generative Recurrent Networks for De Novo Drug Design.
    Gupta A; Müller AT; Huisman BJH; Fuchs JA; Schneider P; Schneider G
    Mol Inform; 2018 Jan; 37(1-2):. PubMed ID: 29095571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of structure- and ligand-based scoring functions for deep generative models: a GPCR case study.
    Thomas M; Smith RT; O'Boyle NM; de Graaf C; Bender A
    J Cheminform; 2021 May; 13(1):39. PubMed ID: 33985583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.